Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Immunology Letters|March 10, 2017
Prospective study of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced renal cell cancerMao Lin, Kecheng Xu, Shuzhen Liang, et al.
Molecular Immunology|October 18, 2017
Tumor cryoablation in combination with natural killer cells therapy and Herceptin in patients with HER2-overexpressing recurrent breast cancerShuzhen Liang, Lizhi Niu, Kecheng Xu, et al.
Biomaterials|October 13, 2009
The development of a tissue-engineered artery using decellularized scaffold and autologous ovine mesenchymal stem cellsYilin Zhao, Su Zhang, Jianyin Zhou, et al.
Frontiers in Immunology|July 9, 2026
Correction: MicroRNA-based integrated diagnosis and therapy for GBM: current status and advancesYe Chen, Huiyi Liu, Peipei Yuan, et al.
Xenotransplantation|December 17, 2010
Combination of antibodies inhibits accelerated rejection mediated by memory T cells in xenoantigen-primed miceFeiyu Wang, Junjie Xia, Jibing Chen, et al.
Immunological Investigations|August 20, 2010
Anti-CD44 monoclonal antibody inhibits heart transplant rejection mediated by alloantigen-primed CD4(+) memory T cells in nude miceFeng Wang, Jibing Chen, Wei Shao, et al.
Oncotarget|November 16, 2017
Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancerMao Lin, Shuzhen Liang, Xiaohua Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 26, 2018
Circulating Tumor DNA as a Sensitive Marker in Patients Undergoing Irreversible Electroporation for Pancreatic CancerMao Lin, Mohammed Alnaggar, Shuzhen Liang, et al.
Cardiovascular and Interventional Radiology|August 29, 2018
Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver CancerYumei Yang, Zilin Qin, Duanming Du, et al.
Frontiers in Immunology|November 12, 2024
Single-cell and bulk transcriptomic datasets enable the development of prognostic models based on dynamic changes in the tumor immune microenvironment in patients with hepatocellular carcinoma and portal vein tumor thrombusWangxia Tong, Jieyue Zhong, Qiuyan Yang, et al.
Pageof 11